Global Financial Private Client’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,601
Closed -$333K 843
2025
Q1
$333K Buy
2,601
+1,961
+306% +$266K 0.13% 162
2024
Q4
$84.6K Hold
640
0.03% 277
2024
Q3
$93.2K Hold
640
0.04% 269
2024
Q2
$87.8K Sell
640
-6
-0.9% -$801 0.04% 250
2024
Q1
$88.4K Sell
646
-1,640
-72% -$224K 0.04% 252
2023
Q4
$311K Buy
2,286
+138
+6% +$16.8K 0.15% 148
2023
Q3
$259K Sell
2,148
-2,661
-55% -$338K 0.13% 150
2023
Q2
$610K Buy
4,809
+33
+0.7% +$4.29K 0.3% 81
2023
Q1
$620K Sell
4,776
-257
-5% -$33.6K 0.32% 75
2022
Q4
$661K Buy
5,033
+1,517
+43% +$196K 0.37% 64
2022
Q3
$419K Buy
3,516
+2,827
+410% +$351K 0.24% 97
2022
Q2
$82.8K Hold
689
0.05% 209
2022
Q1
$91.7K Sell
689
-2,138
-76% -$278K 0.04% 203
2021
Q4
$431K Buy
2,827
+76
+3% +$11.8K 0.21% 96
2021
Q3
$437K Sell
2,751
-210
-7% -$35.3K 0.22% 100
2021
Q2
$489K Buy
2,961
+633
+27% +$97.5K 0.27% 88
2021
Q1
$353K Buy
2,328
+340
+17% +$54K 0.25% 84
2020
Q4
$301K Buy
1,988
+152
+8% +$21.7K 0.24% 82
2020
Q3
$251K Sell
1,836
-107
-6% -$14.5K 0.22% 84
2020
Q2
$267K Sell
1,943
-3
-0.2% -$382 0.23% 88
2020
Q1
$202K Buy
1,946
+6
+0.3% +$691 0.21% 97
2019
Q4
$234K Buy
+1,940
New +$216K 0.2% 103

Other funds holding IBB

Global Financial Private Client's IBB Position: Q2 2025 in Review

Global Financial Private Client sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 2,601 shares — an estimated $333K sold.

Global Financial Private Client first reported a position in IBB in Q4 2019 and held it in 22 quarters. The position peaked at $661K in Q4 2022. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Global Financial Private Client reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 2,601 iShares Biotechnology ETF shares in Q2 2025, an estimated $333K.
  • Global Financial Private Client first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 22 quarters.
  • Global Financial Private Client's iShares Biotechnology ETF position peaked at $661K in Q4 2022.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.